Poolbeg Pharma Share Price | |
---|---|
Price | 13.35 |
Bid | 13.20 |
Ask | 13.50 |
Change | 0.60 (4.71%) |
Volume | 4,983,114 |
Open | 12.75 |
High | 13.70 |
Low | 13.35 |
Prev. Close | 12.75 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 500.00m |
Market Capitalisation | £66.75m |
Market Size | 30,000 |
52 Week High | 13.70 |
52 Week High Date | 03-May-2024 |
52 Week Low | 6.38 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 192 |
---|---|
Vol. Sold | 2,273,346 |
Sold Value | £281.29k |
Vol. Bought | 2,190,785 |
Bought Value | £291.77k |
PE Ratio | -14.20213 |
Earnings | -0.94 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:29:24 | 13.388 | 30,000 | Sell* | 13.20 | 13.60 | 4,016 | O Ordinary |
03-May-24 | 16:28:01 | 13.46 | 671 | Buy* | 13.20 | 13.60 | 90.32 | O Ordinary |
03-May-24 | 16:25:18 | 13.596 | 7,355 | Buy* | 13.20 | 13.60 | 999.99 | O Ordinary |
03-May-24 | 16:22:16 | 13.548 | 73,741 | Buy* | 13.20 | 13.60 | 9,990 | O Ordinary |
03-May-24 | 16:18:00 | 13.50 | 22,548 | Sell* | 13.40 | 13.70 | 3,044 | O Ordinary |
03-May-24 | 16:17:21 | 13.50 | 10,000 | Sell* | 13.50 | 13.70 | 1,350 | O Ordinary |
03-May-24 | 16:17:12 | 13.637 | 21,998 | Buy* | 13.50 | 13.70 | 3,000 | O Ordinary |
03-May-24 | 16:15:29 | 13.70 | 6,152 | Buy* | 13.50 | 13.70 | 842.82 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:15:29 | 13.70 | 7,299 | Buy* | 13.50 | 13.70 | 999.96 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:15:29 | 13.70 | 109 | Buy* | 13.50 | 13.70 | 14.93 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
22-Feb-24 | 21-Feb-24 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 10.80 | GBX | 154,764 | 1,028,261 |
19-Feb-24 | 19-Feb-24 | Buy | Cathal Friel held the position of Executive Chairman at the time of this trade.Cathal Friel | 11.68 | GBX | 830,000 | 37,219,757 |
06-Oct-22 | 05-Oct-22 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 4.78 | GBX | 718,733 | 718,733 |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Patrick J Ashe held the position of Independent Non-Executive Director at the time of this trade.Patrick J Ashe | 0.00 | 0 | 263,147 | |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Cathal Friel held the position of Non-Executive Chairman at the time of this trade.Cathal Friel | 0.00 | 0 | 36,389,757 |
Welcome to Poolbeg Pharma plc which is listed on AIM (AIM:POLB). Keep up to date with our performance & latest news